Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Medicis Pharm

Article Abstract:

The shares of Medicis Pharmaceutical Corp. have above-average price appreciation potential over the 2010-2012 timeframe. The Scottsdale, Arizona-based company provides prescription and non-prescription products for the treatment of dermatological conditions.

Author: Napoli, Michael F.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Evaluation, Stocks, Stock prices

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Medicis Pharmaceuticals

Article Abstract:

A comparative analysis of the company sales and earnings and the financial details of Medicis Pharmaceuticals from 1992 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.

Author: Lewittes, William C.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Sales, profits & dividends, Company sales and earnings, Company earnings/profit

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Pharmaceutical industry, Securities, Company securities, Medicis Pharmaceutical Corp.
Similar abstracts:
  • Abstracts: ISIS Pharm., Inc. Vertex Pharmaceuticals Inc
  • Abstracts: Phelps Dodge. ICN Pharmaceuticals
  • Abstracts: Enzon Pharmaceuticals Inc.. Wyeth
  • Abstracts: IDEC Pharmaceuticals Corp. CDI Corp. Amn Healthcare Services Inc
  • Abstracts: King Pharmaceuticals Inc. Kelly Services. Hewitt Associates Inc
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.